Skip to content

Clinical Study on the Effectiveness of Introducing Advance Care Planning (ACP) in Older Adults in Response to COVID-19 (coronavirus disease 2019)

Clinical Study on the Effectiveness of Introducing Advance Care Planning (ACP) in Older Adults in Response to COVID-19 (coronavirus disease 2019) - Clinical Study on the Effectiveness of Introducing ACP in Older Adults in Response to COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052366
Enrollment
90
Registered
2023-10-10
Start date
2021-02-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geriatric diseases

Interventions

All study participants were provided with ACP leaflets supervised by the Ministry of Health, Labour and Welfare, which were handed out by collaborating researchers. For the intervention group, an expl

Sponsors

Saitama Medical Center, Jichi Medical University, Division of General Medicine, Department of the Comprehensive Medicine 1, Hanako Yoshihara (Kurihara)
Lead Sponsor
Minamiuonuma City Hospital, Kyosai Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study participants consisted of Japanese outpatient patients aged 65 and older for whom informed consent had been obtained.

Exclusion criteria

Exclusion criteria: Individuals with dementia, severe hearing impairment, those for whom the attending physician clearly determined a prognosis of less than one month, and those who could not provide consent were excluded from the study.

Design outcomes

Primary

MeasureTime frame
The primary outcome was the proportion of participants who reported having an ACP discussion with his/her families at 3 months after enrollment.

Secondary

MeasureTime frame
The secondary outcomes included the following measures: scores on the four evaluation items of the Advance Care Planning Engagement Survey at 3 months, Advance Directive completion at 3 months, the determination of the surrogate decision-maker's role at 3 months, and the occurrence of post-intervention anxiety assessed in part using the GAD-7 scale.

Countries

Japan

Contacts

Public ContactHanako Yoshihara (Kurihara)

Saitama Medical Center, Jichi Medical University Division of General Medicine, Department of the Comprehensive Medicine 1

chibihana.0701@gmail.com0486472111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026